SCINAI IMMUNOTHERAPEUTICS LTD. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2022-12-29: Form 6-K; Period of report 2022-12-29; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea170933-6k_biondvax.htm.
- 2022-12-20: Form 6-K; Period of report 2022-12-20; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea170536-6k_biondvax.htm.
- 2022-12-19: Form 6-K; Period of report 2022-12-19; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea170408-6k_biondvaxpharma.htm.
- 2022-12-14: Form 6-K; Period of report 2022-12-14; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea170179-6k_biondvaxpharma.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2022-12-29 | 6-K | 2022-12-29 | REPORT OF FOREIGN PRIVATE ISSUER | ea170933-6k_biondvax.htm |
| 2022-12-20 | 6-K | 2022-12-20 | REPORT OF FOREIGN PRIVATE ISSUER | ea170536-6k_biondvax.htm |
| 2022-12-19 | 6-K | 2022-12-19 | REPORT OF FOREIGN PRIVATE ISSUER | ea170408-6k_biondvaxpharma.htm |
| 2022-12-14 | 6-K | 2022-12-14 | REPORT OF FOREIGN PRIVATE ISSUER | ea170179-6k_biondvaxpharma.htm |
| 2022-12-14 | 6-K | 2022-12-14 | REPORT OF FOREIGN PRIVATE ISSUER | ea170164-6k_biondvaxpharma.htm |
| 2022-11-30 | 6-K | 2022-11-30 | REPORT OF FOREIGN PRIVATE ISSUER | ea169475-6k_biondvaxpharma.htm |
| 2022-11-29 | 6-K | 2022-11-29 | REPORT OF FOREIGN PRIVATE ISSUER | ea169387-6k_bionvaxpharm.htm |
| 2022-11-10 | 6-K | 2022-11-10 | CURRENT REPORT | f6k1122_biondvax.htm |
| 2022-11-08 | 6-K | 2022-11-08 | REPORT OF FOREIGN PRIVATE ISSUER | ea168252-6k_biondvaxpharma.htm |
| 2022-11-04 | 6-K | 2022-11-04 | REPORT OF FOREIGN PRIVATE ISSUER | ea168014-6k_biondvaxpharma.htm |
| 2022-10-03 | 6-K | 2022-10-03 | REPORT OF FOREIGN PRIVATE ISSUER | ea166652-6k_biondvaxpharma.htm |
| 2022-09-21 | 6-K | 2022-09-21 | REPORT OF FOREIGN PRIVATE ISSUER | ea166108-6k_biondvax.htm |
| 2022-08-29 | 6-K/A | 2022-06-30 | AMENDMENT NO. 1 TO FORM 6-K | ea165093-6ka1_biondvax.htm |
| 2022-08-25 | 6-K | 2022-08-25 | REPORT OF FOREIGN PRIVATE ISSUER | ea164969-6k_biondvax.htm |
| 2022-08-10 | 6-K | 2022-08-10 | REPORT OF FOREIGN PRIVATE ISSUER | ea164134-6k_biondvax.htm |
| 2022-06-08 | 6-K | 2022-06-08 | REPORT OF FOREIGN PRIVATE ISSUER | ea161318-6k_biondvax.htm |
| 2022-06-03 | 6-K | 2022-06-03 | REPORT OF FOREIGN PRIVATE ISSUER | ea161124-6k_biondvax.htm |
| 2022-05-18 | 6-K | 2022-05-18 | REPORT OF FOREIGN PRIVATE ISSUER | ea160222-6k_biondvax.htm |
| 2022-05-13 | 6-K | 2022-05-13 | REPORT OF FOREIGN PRIVATE ISSUER | ea159822-6k_biondvax.htm |
| 2022-04-12 | 6-K | 2022-04-12 | REPORT OF FOREIGN PRIVATE ISSUER | ea158319-6k_biondvaxpharm.htm |
| 2022-04-08 | 6-K | 2022-04-08 | REPORT OF FOREIGN PRIVATE ISSUER | ea158230-6k_biondvaxpharm.htm |
| 2022-04-04 | 6-K | 2022-04-04 | REPORT OF FOREIGN PRIVATE ISSUER | ea157994-6k_biondvaxpharm.htm |
| 2022-04-04 | 6-K | 2022-04-04 | REPORT OF FOREIGN PRIVATE ISSUER | ea157935-6k_biondvaxpharm.htm |
| 2022-01-11 | 6-K | 2022-01-10 | REPORT OF FOREIGN PRIVATE ISSUER | ea153774-6k_biondvaxpharma.htm |